v3.25.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Millions
Total
Common stock
Treasury stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss) – net
Equity attributable to noncontrolling interests
Equity, beginning balance (in shares) at Dec. 31, 2023   455,000,000          
Equity, beginning balance at Dec. 31, 2023 $ 7,145 $ 5   $ 6,493 $ 1,326 $ (691) $ 12
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)   1,000,000          
Issuance of shares under equity awards, net of shares withheld for taxes and other (24)     (24)      
Net income attributable to GE HealthCare 374       374    
Dividends declared (14)       (14)    
Other comprehensive income (loss) attributable to GE HealthCare (95)         (95)  
Changes in equity attributable to noncontrolling interests 2           2
Share-based compensation 34     34      
Equity, ending balance (in shares) at Mar. 31, 2024   456,000,000          
Equity, ending balance at Mar. 31, 2024 $ 7,423 $ 5   6,504 1,687 (787) 14
Equity, beginning balance (in shares) at Dec. 31, 2024 457,246,971 457,000,000          
Equity, beginning balance at Dec. 31, 2024 $ 8,464 $ 5 $ (25) 6,583 3,262 (1,379) 18
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 291,053   0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)   1,000,000          
Issuance of shares under equity awards, net of shares withheld for taxes and other $ (9)     (9)      
Net income attributable to GE HealthCare 564       564    
Dividends declared (16)       (16)    
Other comprehensive income (loss) attributable to GE HealthCare 180         180  
Changes in equity attributable to noncontrolling interests 1           1
Share-based compensation $ 22     22      
Equity, ending balance (in shares) at Mar. 31, 2025 458,134,263 458,000,000          
Equity, ending balance at Mar. 31, 2025 $ 9,207 $ 5 $ (25) $ 6,597 $ 3,810 $ (1,199) $ 20
Treasury stock, ending balance (in shares) at Mar. 31, 2025 291,053   0